SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication

被引:21
|
作者
Shao, Run-Xuan [3 ]
Zhang, Leiliang [1 ,2 ,3 ]
Hong, Zhi [1 ,2 ]
Goto, Kaku [3 ]
Cheng, Du [3 ]
Chen, Wen-Chi [3 ]
Jilg, Nikolaus [3 ]
Kumthip, Kattareeya [3 ]
Fusco, Dahlene N. [3 ]
Peng, Lee F. [3 ]
Chung, Raymond T. [3 ]
机构
[1] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100730, Peoples R China
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
Hepatitis C virus; SOCS1; Interferon; ISG; JFH1; JAK-STAT PATHWAY; INTERFERON-ALPHA; RIBAVIRIN; CYTOKINE; ACTIVATION; SUPPRESSOR; EXPRESSION; INHIBITOR; INFECTION; PROTEINS;
D O I
10.1016/j.antiviral.2012.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Suppressor of cytokine signaling 1 (SOCS1) and suppressor of cytokine signaling 3 (SOCS3) have been thought to block type I interferon (IFN) signaling. We have previously reported that SOCS3 suppresses HCV replication in an mTOR-dependent manner. However, the relationship between SOCS1 and HCV replication remains unclear. Here, we found that overexpression of SOCS1 alone did not have an effect on HCV RNA replication. However, suppression of HCV replication by IFN-alpha, was rescued by SOCS1 overexpression. The upregulation of HCV replication by SOCS1 overexpression in the presence of IFN is likely a result of the impairment of IFN signaling by SOCS1 and subsequent induction of ISGs. Knockdown of SOCS1 alone with specific shRNA enhanced the antiviral effect of IFN compared with negative control. Thus, SOCS1 acts as a suppressor of type I IFN function against HCV. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 50 条
  • [21] Blocking neddylation elicits antiviral effect against hepatitis B virus replication
    Abounouh, Karima
    Kayesh, Mohammad Enamul Hoque
    Altawalah, Haya
    Kitab, Bouchra
    Murakami, Shuko
    Ogawa, Shintaro
    Tanaka, Yasuhito
    Dehbi, Hind
    Pineau, Pascal
    Kohara, Michinori
    Benjelloun, Soumaya
    Tsukiyama-Kohara, Kyoko
    Ezzikouri, Sayeh
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (01) : 403 - 412
  • [22] THE EFFECT OF 3 KNOWN ANTIVIRAL SUBSTANCES ON HEPATITIS-A VIRUS-REPLICATION
    DECHASTONAY, J
    SIEGL, G
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A134 - A134
  • [23] MODULATION OF IFNα/β TRANSCRIPTOME BY HEPATITIS B VIRUS REPLICATION
    Testoni, Barbara
    Lucifora, Julie
    Belloni, Laura
    Scisciani, Cecilia
    Durantel, David
    Zoulim, Fabien
    Levrero, Massimo
    HEPATOLOGY, 2009, 50 (04) : 990A - 991A
  • [24] SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis
    Yoshida, T
    Yoshimura, A
    Sata, M
    GASTROENTEROLOGY, 2004, 126 (04) : A752 - A752
  • [25] Replication of hepatitis C virus
    Moradpour, Darius
    Penin, Francois
    Rice, Charles M.
    NATURE REVIEWS MICROBIOLOGY, 2007, 5 (06) : 453 - 463
  • [26] Quantifying the Antiviral Effect of IFN on HIV-1 Replication in Cell Culture
    Ikeda, Hiroki
    Godinho-Santos, Ana
    Rato, Sylvie
    Vanwalscappel, Benedicte
    Clavel, Francois
    Aihara, Kazuyuki
    Iwami, Shingo
    Mammano, Fabrizio
    SCIENTIFIC REPORTS, 2015, 5
  • [27] Quantifying the Antiviral Effect of IFN on HIV-1 Replication in Cell Culture
    Hiroki Ikeda
    Ana Godinho-Santos
    Sylvie Rato
    Bénédicte Vanwalscappel
    François Clavel
    Kazuyuki Aihara
    Shingo Iwami
    Fabrizio Mammano
    Scientific Reports, 5
  • [28] Replication of the hepatitis C virus
    Bartenschlager, R
    Lohmann, V
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (02) : 241 - 254
  • [29] Replication of hepatitis C virus
    Darius Moradpour
    François Penin
    Charles M. Rice
    Nature Reviews Microbiology, 2007, 5 : 453 - 463
  • [30] Hepatitis C Virus Replication
    Suzuki, Tetsuro
    ORGANELLE CONTACT SITES: FROM MOLECULAR MECHANISM TO DISEASE, 2017, 997 : 199 - 209